•• Tsunakawa Y, Hamada M, Matsunaga Y, Fuseya S, Jeon H, Wakimoto Y, et al. Mice harboring an MCTO mutation exhibit renal failure resembling nephropathy in human patients. Exp Anim 2019;68(1):103-11. https://doi.org/10.1538/expanim.18-0093. This paper reports the generation of a mouse harboring a human MCTO mutation using CRISPR/Cas9 technology. The mice develop a renal phenotype that resembles nephropathy in patients with MCTO.
• Wu J, Wang L, Xu Y, Zhang Z, Yan X, An Y, et al. Multicentric carpo-tarsal osteolysis syndrome mimicking juvenile idiopathic arthritis: two case reports and review of the literature. Front Pediatr 2021;9:745812. Overview of the clinical and genetic features of 51 published cases of genetically confirmed MCTO.
Wang PW, Eisenbart JD, Cordes SP, Barsh GS, Stoffel M, Le Beau MM. Human KRML (MAFB): cDNA cloning, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias. Genomics. 1999;59(3):275–81.
•• Zankl A, Duncan EL, Leo PJ, Clark GR, Glazov EA, Addor MC, et al. Multicentric carpotarsal osteolysis is caused by mutations clustering in the amino-terminal transcriptional activation domain of MAFB. Am J Hum Genet 2012;90(3): 494-501. This paper identified MAFB as the genetic basis for MCTO.
Tsuchiya M, Misaka R, Nitta K, Tsuchiya K. Transcriptional factors, Mafs and their biological roles. World J Diabetes. 2015;6(1):175–83. https://doi.org/10.4239/wjd.v6.i1.175.
Katsuoka F, Yamamoto M. Small Maf proteins (MafF, MafG, MafK): history, structure and function. Gene. 2016;586(2):197–205.
Kataoka K, Noda M, Nishizawa M. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol. 1994;14(1):700–12.
Wu Z, Nicoll M, Ingham RJ. AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL. Exp Hematol Oncol. 2021;10(1):4.
Takahashi S. Functional analysis of large MAF transcription factors and elucidation of their relationships with human diseases. Exp Anim. 2021;70(3):264–71.
Mehawej C, Courcet JB, Baujat G, Mouy R, Gerard M, Landru I, et al. The identification of MAFB mutations in eight patients with multicentric carpo-tarsal osteolysis supports genetic homogeneity but clinical variability. Am J Med Genet A 2013;161a(12): 3023-3029.
Zhuang L, Adler S, Aeberli D, Villiger PM, Trueb B. Identification of a MAFB mutation in a patient with multicentric carpotarsal osteolysis. Swiss Med Wkly. 2017;147:w14529.
Chen K, Zamariolli M, Soares MFF, Meloni VA, Melaragno MI. Multicentric carpotarsal osteolysis syndrome in a mother and daughter with a MAFB missense variant and natural history of the disease. Mol Syndromol. 2022;13(1):50–5.
Li J, Shi L, Lau K, Ma Y, Jia S, Gao X. Identification of a novel mutation in the MAFB gene in a pediatric patient with multicentric carpotarsal osteolysis syndrome using next-generation sequencing. Eur J Med Genet. 2020;63(6):103902.
Mumm S, Huskey M, Duan S, Wenkert D, Madson KL, Gottesman GS, et al. Multicentric carpotarsal osteolysis syndrome is caused by only a few domain-specific mutations in MAFB, a negative regulator of RANKL-induced osteoclastogenesis. Am J Med Genet A 2014;164a(9): 2287-2293.
Choochuen P, Rojneuangnit K, Khetkham T, Khositseth S. The first report of multicentric carpotarsal osteolysis syndrome caused by MAFB mutation in Asian. Case Rep Med 2018: 6783957.
Upadia J, Gomes A, Weiser P, Descartes M. A familial case of multicentric carpotarsal osteolysis syndrome and treatment outcome. J Pediatr Genet. 2018;7(4):174–9.
Regev R, Sochett EB, Elia Y, Laxer RM, Noone D, Whitney-Mahoney K, Filipowski K, Shamas A, Vali R. Multicentric carpotarsal osteolysis syndrome (MCTO) with generalized high bone turnover and high serum RANKL: Response to denosumab. Bone Rep. 2021;14:100747.
Dworschak GC, Draaken M, Hilger A, Born M, Reutter H, Ludwig M. An incompletely penetrant novel MAFB (p.Ser56Phe) variant in autosomal dominant multicentric carpotarsal osteolysis syndrome. Int J Mol Med. 2013;32(1):174–8.
Sun K, Barlow B, Malik F, Inglis A, Figgie M, Goodman S. Total hip arthroplasty in a patient with multicentric carpotarsal osteolysis: a case report. Hss J. 2016;12(2):177–81.
Park PG, Kim KH, Hyun HS, Lee CH, Park JS, Kie JH, Choi YH, Moon KC, Cheong HI. Three cases of multicentric carpotarsal osteolysis syndrome: a case series. BMC Med Genet. 2018;19(1):164.
• Närhi A, Fernandes A, Toiviainen-Salo S, Harris J, McInerney-Leo A, Lazarus S, et al. A family with partially penetrant multicentric carpotarsal osteolysis due to gonadal mosaicism: first reported case. Am J Med Genet A 2021;185(8): 2477-2481. First reported case of partially penetrant MCTO due to genetic mosaicism.
Stajkovska A, Mehandziska S, Stavrevska M, Jakovleva K, Nikchevska N, Mitrev Z, Kungulovski I, Zafiroski G, Tasic V, Kungulovski G. Trio clinical exome sequencing in a patient with multicentric carpotarsal osteolysis syndrome: first case report in the Balkans. Front Genet. 2018;9:113.
Ma NS. Symptoms of multicentric carpotarsal osteolysis respond to anti-inflammatory treatment. 2020 Annual Meeting of the American Society for Bone and Mineral Research Virtual Event September 11-15, 2020. J Bone Miner Res 2020 Nov;35 Suppl 1:S1-S349. https://doi.org/10.1002/jbmr.4206.
Han SI, Aramata S, Yasuda K, Kataoka K. MafA stability in pancreatic beta cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3. Mol Cell Biol. 2007;27(19):6593–605. https://doi.org/10.1128/MCB.01573-06.
Rocques N, Abou Zeid N, Sii-Felice K, Lecoin L, Felder-Schmittbuhl MP, Eychene A, et al. GSK-3-mediated phosphorylation enhances Maf-transforming activity. Mol Cell. 2007;28(4):584–97. https://doi.org/10.1016/j.molcel.2007.11.009.
Herath NI, Rocques N, Garancher A, Eychene A, Pouponnot C. GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target. Blood Cancer J. 2014;4:e175. https://doi.org/10.1038/bcj.2013.67.
Niceta M, Stellacci E, Gripp KW, Zampino G, Kousi M, Anselmi M, Traversa A, Ciolfi A, Stabley D, Bruselles A, Caputo V, Cecchetti S, Prudente S, Fiorenza MT, Boitani C, Philip N, Niyazov D, Leoni C, Nakane T, et al. Mutations impairing GSK3-mediated MAF phosphorylation cause cataract, deafness, intellectual disability, seizures, and a down syndrome-like facies. Am J Hum Genet. 2015;96(5):816–25. https://doi.org/10.1016/j.ajhg.2015.03.001.
Bialkowska AB, Liu Y, Nandan MO, Yang VW. A colon cancer-derived mutant of Kruppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3beta (GSK3beta) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7alpha (FBW7alpha). J Biol Chem. 2014;289(9):5997–6005. https://doi.org/10.1074/jbc.M113.508549.
He P, Yang JW, Yang VW, Bialkowska AB. Kruppel-like factor 5, Increased in pancreatic ductal adenocarcinoma, promotes proliferation, acinar-to-ductal metaplasia, pancreatic intraepithelial neoplasia, and tumor growth in mice. Gastroenterology. 2018;154(5):1494–508 e13. https://doi.org/10.1053/j.gastro.2017.12.005.
Chen Q, Dowhan DH, Liang D, Moore DD, Overbeek PA. CREB-binding protein/p300 co-activation of crystallin gene expression. J Biol Chem. 2002;277(27):24081–9.
Guo S, Burnette R, Zhao L, Vanderford NL, Poitout V, Hagman DK, Henderson E, Özcan S, Wadzinski BE, Stein R. The stability and transactivation potential of the mammalian MafA transcription factor are regulated by serine 65 phosphorylation. J Biol Chem. 2009;284(2):759–65. https://doi.org/10.1074/jbc.M806314200.
Benkhelifa S, Provot S, Nabais E, Eychene A, Calothy G, Felder-Schmittbuhl MP. Phosphorylation of MafA is essential for its transcriptional and biological properties. Mol Cell Biol. 2001;21(14):4441–52. https://doi.org/10.1128/MCB.21.14.4441-4452.2001.
Guo S, Vanderford NL, Stein R. Phosphorylation within the MafA N terminus regulates C-terminal dimerization and DNA binding. J Biol Chem. 2010;285(17):12655–61. https://doi.org/10.1074/jbc.M110.105759.
He Y, Wang S, Tong J, Jiang S, Yang Y, Zhang Z, Xu Y, Zeng Y, Cao B, Moran MF, Mao X. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. J Biol Chem. 2020;295(7):2084–96. https://doi.org/10.1074/jbc.RA119.010724.
Giudicelli F, Gilardi-Hebenstreit P, Mechta-Grigoriou F, Poquet C, Charnay P. Novel activities of Mafb underlie its dual role in hindbrain segmentation and regional specification. Dev Biol. 2003;253(1):150–62. https://doi.org/10.1006/dbio.2002.0864.
Vazquez-Echeverria C, Dominguez-Frutos E, Charnay P, Schimmang T, Pujades C. Analysis of mouse kreisler mutants reveals new roles of hindbrain-derived signals in the establishment of the otic neurogenic domain. Dev Biol. 2008;322(1):167–78. https://doi.org/10.1016/j.ydbio.2008.07.025.
Conrad E, Dai C, Spaeth J, Guo M, Cyphert HA, Scoville D, Carroll J, Yu WM, Goodrich LV, Harlan DM, Grove KL, Roberts CT Jr, Powers AC, Gu G, Stein R. The MAFB transcription factor impacts islet alpha-cell function in rodents and represents a unique signature of primate islet beta-cells. Am J Physiol Endocrinol Metab. 2016;310(1):E91–E102. https://doi.org/10.1152/ajpendo.00285.2015.
Iacovazzo D, Flanagan SE, Walker E, Quezado R, de Sousa Barros FA, Caswell R, Johnson MB, Wakeling M, Brändle M, Guo M, Dang MN, Gabrovska P, Niederle B, Christ E, Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, et al. MAFA missense mutation causes familial insulinomatosis and diabetes mellitus. Proc Natl Acad Sci USA. 2018;115(5):1027–32. https://doi.org/10.1073/pnas.1712262115.
Hang Y, Stein R. MafA and MafB activity in pancreatic beta cells. Trends Endocrinol Metab. 2011;22(9):364–73. https://doi.org/10.1016/j.tem.2011.05.003.
Miyatsuka T, Matsuoka TA, Kaneto H. Transcription factors as therapeutic targets for diabetes. Expert Opin Ther Targets. 2008;12(11):1431–42.
Kamitani-Kawamoto A, Hamada M, Moriguchi T, Miyai M, Saji F, Hatamura I, Nishikawa K, Takayanagi H, Hitoshi S, Ikenaka K, Hosoya T, Hotta Y, Takahashi S, Kataoka K. MafB interacts with Gcm2 and regulates parathyroid hormone expression and parathyroid development. J Bone Miner Res. 2011;26(10):2463–72. https://doi.org/10.1002/jbmr.458.
Sadl V, Jin F, Yu J, Cui S, Holmyard D, Quaggin S, et al. The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. Dev Biol. 2002;249(1):16–29. https://doi.org/10.1006/dbio.2002.0751.
Moriguchi T, Hamada M, Morito N, Terunuma T, Hasegawa K, Zhang C, Yokomizo T, Esaki R, Kuroda E, Yoh K, Kudo T, Nagata M, Greaves DR, Engel JD, Yamamoto M, Takahashi S. MafB is essential for renal development and F4/80 expression in macrophages. Mol Cell Biol. 2006;26(15):5715–27. https://doi.org/10.1128/mcb.00001-06.
Brunskill EW, Georgas K, Rumballe B, Little MH, Potter SS. Defining the molecular character of the developing and adult kidney podocyte. PLoS One. 2011;6(9):e24640. https://doi.org/10.1371/journal.pone.0024640.
Kim K, Kim JH, Lee J, Jin HM, Kook H, Kim KK, Lee SY, Kim N. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood. 2007;109(8):3253–9. https://doi.org/10.1182/blood-2006-09-048249.
Howell K, Posluszny J, He LK, Szilagyi A, Halerz J, Gamelli RL, Shankar R, Muthu K. High MafB expression following burn augments monocyte commitment and inhibits DC differentiation in hemopoietic progenitors. J Leukoc Biol. 2012;91(1):69–81. https://doi.org/10.1189/jlb.0711338.
留言 (0)